Print Page  Close Window

SEC Filings

SC 13G/A
UBS OCONNOR LLC filed this Form SC 13G/A on 02/12/2019
Entire Document



Washington, D.C. 20549




Under the Securities Exchange Act of 1934


(Amendment No. 1)*


Orexigen Therapeutics, Inc.


(Name of Issuer)


Common Stock, $0.001 par value per share


(Title of Class of Securities)



(CUSIP Number)


December 31, 2018


(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


a.☒ Rule 13d-1(b)
b.☐ Rule 13d-1(c)
c. ☐ Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




Page 1 of 6